Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;8(4):343-57.
doi: 10.3400/avd.tasc.15-01000. Epub 2015 Oct 23.

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.)

Michael R Jaff  1 , Christopher J White  2 , William R Hiatt  3 , Gerry R Fowkes  4 , John Dormandy  5 , Mahmood Razavi  6 , Jim Reekers  7 , Lars Norgren  8
Affiliations

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.)

Michael R Jaff et al. Ann Vasc Dis. 2015.

Abstract

The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) guidelines were last updated in 2007 (TASC II) and represented the collaboration of international vascular specialties involved in the management of patients with peripheral arterial disease (PAD). Since the publication of TASC II, there have been innovations in endovascular revascularization strategies for patients with PAD. The intent of this publication is to provide a complete anatomic lower limb TASC lesion classification, including the infrapopliteal segment, and an updated literature review of new endovascular techniques and practice patterns employed by vascular specialists today.

Keywords: angioplasty; arteries; claudication; critical limb ischemia; occlusion; peripheral artery disease; revascularization; stenosis; stents; surgery.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) classification of aortoiliac lesions. AAA: abdominal aortic aneurysm; CFA: common femoral artery; CIA: common iliac artery; EIA: external iliac artery
Fig. 2
Fig. 2
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) classification of femoral popliteal lesions. CFA: common femoral artery; SFA: superficial femoral artery
Fig. 3
Fig. 3
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) classification of infrapopliteal lesions. The unshaded area represents the target lesion; area inside the shaded rectangle represents typical background disease (see text for further explanation).
See this image and copyright information in PMC

References

    1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31: S1-S296. - PubMed
    1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S: S5-67. - PubMed
    1. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-92. - PubMed
    1. Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-32. - PubMed
    1. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008; 118: 1358-65. - PubMed

LinkOut - more resources